Author: Boeddinghaus, Jasper; Nestelberger, Thomas; Kaiser, Christoph; Twerenbold, Raphael; Fahrni, Gregor; Bingisser, Roland; Khanna, Nina; Tschudin-Sutter, Sarah; Widmer, Andreas; Jeger, Raban; Kaufmann, Beat; Pfister, Otmar; Sticherling, Christian; Müller, Christian; Osswald, Stefan; Zellweger, Michael J.; Kühne, Michael
Title: Effect of COVID-19 on acute treatment of ST-segment elevation and Non-ST-segment elevation acute coronary syndrome in northwestern Switzerland Cord-id: s44x7cn5 Document date: 2020_12_4
ID: s44x7cn5
Snippet: BACKGROUND: To investigate the effect of the corona virus disease 2019 (COVID-19) pandemic on the acute treatment of patients with ST-segment elevation (STEMI) and Non-ST-segment elevation acute coronary syndrome (NSTE-ACS). METHODS: We retrospectively identified patients presenting to the emergency department (ED) with suspected ACS. We evaluated the number of percutaneous coronary interventions (PCIs) for STEMI, NSTE-ACS, and elective PCI cases. In STEMI patients, we assessed the time from che
Document: BACKGROUND: To investigate the effect of the corona virus disease 2019 (COVID-19) pandemic on the acute treatment of patients with ST-segment elevation (STEMI) and Non-ST-segment elevation acute coronary syndrome (NSTE-ACS). METHODS: We retrospectively identified patients presenting to the emergency department (ED) with suspected ACS. We evaluated the number of percutaneous coronary interventions (PCIs) for STEMI, NSTE-ACS, and elective PCI cases. In STEMI patients, we assessed the time from chest pain onset (cpo) to ED presentation, post-infarction left ventricular ejection fraction (LVEF), and time from ED presentation to PCI. We directly compared cases from two time intervals: January/February 2020 versus March/April 2020 (defined as 2 months before and after the COVID-19 outbreak). In a secondary analysis, we directly compared cases from March/April 2020 with patients from the same time interval in 2019. RESULTS: From January to April 2020, 765 patients presented with acute chest pain to the ED. A dramatic reduction of ED presentations after compared to before the COVID-19 outbreak (31% relative reduction) was observed. Overall, 398 PCIs were performed, 220/398 PCIs (55.3%) before versus 178/398 PCIs (44.7%) after the outbreak. While numbers for NSTE-ACS and elective interventions declined by 21% and 31%, respectively, the number of STEMI cases remained stable. Time from cpo to ED presentation, post-infarction LVEF, and median door-to-balloon time remained unchanged. CONCLUSIONS: In contrast to previous reports, our findings do not confirm the dramatic drop in STEMI cases and interventions in northwestern Switzerland as observed in other regions and hospitals around the world.
Search related documents:
Co phrase search for related documents- absolute change and acute treatment: 1
- absolute number and acs acute coronary syndrome: 1
- absolute number and acute coronary syndrome: 1, 2, 3
- absolute number and acute treatment: 1, 2
- academic research consortium and acs acute coronary syndrome: 1, 2
- academic research consortium and acute coronary syndrome: 1, 2, 3, 4
- accurate treatment and acute treatment: 1, 2, 3
- acs acute coronary syndrome and acute chest pain: 1, 2, 3, 4
- acs acute coronary syndrome and acute chest pain presentation: 1
- acs acute coronary syndrome and acute coronary syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acs acute coronary syndrome and acute treatment: 1, 2, 3, 4, 5
- acs acute coronary syndrome and long short: 1, 2, 3
- acs acute coronary syndrome and long short term: 1, 2, 3
- acs acute coronary syndrome main symptom and acute chest pain: 1
- acs acute coronary syndrome main symptom and acute coronary syndrome: 1
Co phrase search for related documents, hyperlinks ordered by date